Doctor Niccolo Bonini

Doctor Niccolo Bonini

Modena Polyclinic Modena University Hospital, Modena (Italy)

Member of:

Niccolò Bonini, MD, is a cardiologist at Policlinico di Modena and an Honorary Research Fellow at the Liverpool Centre for Cardiovascular Science (LCCS). His clinical and research interests focus on the interplay between heart failure and atrial fibrillation, their integrated clinical and pharmacological management, and the use of digital health technologies for cardiovascular patient monitoring.

Presentations Articles

Hyperkalemia events in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan or sodium-glucose transport protein 2 inhibitors: a single-center experience

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Towards optimisation of heart failure therapies

Access

Full guideline-directed medical therapy in heart failure patients with reduced ejection fraction: a real-world analysis in older patients with outcome implication

Event: Heart Failure 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Prediction and monitoring in heart failure

Access

Impact of af on sacubitril/valsartan dosing, persistance of treatment and associated outcomes in heart failure patients with reduced ejection fraction

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Acute heart failure - pharmacotherapy 2

Access

Early rhythm control in patients with atrial fibrillation and heart failure: association with long-term outcome in a large european cohort

Event: Heart Failure 2023

Topic: Heart Failure in Atrial Fibrillation

Session: Arrythmias and device therapy in chronic heart failure

Access

Heart failure and cardiovascular outcomes in european patients with atrial fibrillation

Event: ESC Congress 2022

Topic: Imaging

Session: Individual treatment strategies in atrial fibrillation

Access

ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Chronic heart failure and atrial fibrillation

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Niccolo Bonini

Biography

Contributor content

Hyperkalemia events in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan or sodium-glucose transport protein 2 inhibitors: a single-center experience

Full guideline-directed medical therapy in heart failure patients with reduced ejection fraction: a real-world analysis in older patients with outcome implication

Impact of af on sacubitril/valsartan dosing, persistance of treatment and associated outcomes in heart failure patients with reduced ejection fraction

Early rhythm control in patients with atrial fibrillation and heart failure: association with long-term outcome in a large european cohort

Heart failure and cardiovascular outcomes in european patients with atrial fibrillation

ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation

ESC 365 is supported by

Doctor Niccolo Bonini Follow

Biography

Contributor content

Hyperkalemia events in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan or sodium-glucose transport protein 2 inhibitors: a single-center experience

Full guideline-directed medical therapy in heart failure patients with reduced ejection fraction: a real-world analysis in older patients with outcome implication

Impact of af on sacubitril/valsartan dosing, persistance of treatment and associated outcomes in heart failure patients with reduced ejection fraction

Early rhythm control in patients with atrial fibrillation and heart failure: association with long-term outcome in a large european cohort

Heart failure and cardiovascular outcomes in european patients with atrial fibrillation

ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation

ESC 365 is supported by

Doctor Niccolo Bonini